NET PROFIT (x1000 EUR)
EMPLOYEES
Acadia Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-3
|
-8
|
-10 |
| Total assets |
1
|
1
|
0 |
| Current assets |
1
|
1
|
0 |
| Current liabilities |
80
|
78
|
69 |
| Equity capital |
-79
|
-76
|
-68 |
| - share capital |
81
|
81
|
80 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
-7900%
|
-7600% | |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
1.2%
|
1.3%
|
0% |
| Return on equity (ROE) |
3.8%
|
10.5%
|
14.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.